U.S., Feb. 4 -- An application to own the trademark for 'KATPRIFVI' has been filed on Oct. 01, 2025.
Owner(s):
Pfizer Inc.; 66 Hudson Boulevard East, , NEW YORK
Goods and/or Services:
For: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, hormonal disorders, skin disorders, arthritis, cancer, cachexia, hypertension, migraine, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives; Medicated...